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Abstract 
The existing evidence base in relation to the feasibility of using Virtual Reality technology systems with individuals living with a 
dementia appeared limited and was therefore explored. The research was collected and reviewed in terms of the different types 
of Virtual Reality systems (equipment and levels of immersion) and feasibility of the technology within different stages of demen-
tia as well as the methodological limitations. A systematic search of the literature was conducted using the healthcare databases 
advanced search (Medline, PsychINFO, and EMBASE) and snowballing methods. The participants had a dementia diagnosis 
and the feasibility of Virtual Reality in terms of its acceptability and practicality was discussed. Only five articles met the eligibility 
criteria. Four included semi-immersive Virtual Reality with participants in the early stages of dementia. One included fully-
immersive Virtual Reality where dementia stage ranged from ‘mild’ to ‘severe’. Based on available demographic information, 
study participants resided in residential care homes, alone in the community or with their spouse. The existing literature sug-
gests that both semi and fully-immersive Virtual Reality technology use can be feasible amongst individuals living within the ear-
lier stages of dementia outside of a hospital environment, with it being viewed as a welcomed distraction that increased alert-
ness and pleasure. However, Virtual Reality was also found to increase fear and anxiety in one study, raising important ethical 
implications around the safety of the user.  The current evidence-base leaves a predominant gap in Virtual Reality technology 
system use for people within the moderate to later stages of dementia and those living in a hospital environment.  
CCS Concepts 
• Human-centered computing  → Interaction paradigms → Virtual reality; • Social and professional topics → Medical information 
































                                                                








Dementia is an umbrella term describing a set of symptoms 
linked to disorders of the brain that progress over time.  The cog-
nitive and behavioral profile varies according to the type of de-
mentia, as well as progression of the pathology and individual 
patient differences [Alz17]. However, symptoms can include: 
agitation; aggression; a significant decline in social functions and 
difficulty undertaking activities of daily living [LST*00; KG00]. 
Apathy is also a common symptom in dementia, affecting over a 
quarter of the sample population (27%) in some instances 
[LST*00]. In addition, symptoms can include sexual disinhibition, 
problems with eating, abnormal vocalization and depression 
[DJB04] [KH09]. It is proposed that depression is a potential risk 
factor for the development of dementia, as well as a potential 
early symptom of dementia [MV10]. Cognitive ability may decline 
as a reaction to co-existing symptoms of depression, including 
social withdrawal, lack of motivation and loss of interest in oneself 
and others [Kit15]. Physical symptoms of dementia including 
weight loss, and muscle weaknesses may also be evident in the 
later stages of dementia [Alz17]. 
1.1 The National Context 
The Alzheimer Society’s research explored the social and eco-
nomic impact of dementia in the UK. An estimated 850,000 peo-
ple living with dementia in 2015 was indicated, totaling £26 billion 
per year in costs to healthcare. The prevalence of dementia in the 
UK is projected to increase by 40 percent by 2025 and 157 per-
cent by 2051 [PKG*14]. In the US, 5.7 million people are living 
with Alzheimer’s disease, which is predicted to increase with 
population growth of those aged 65 and older from 53 million in 
2018 to 88 million by 2050 [Alz18]. Worldwide, dementia is esti-
mated to affect 35 million people [Dep14].    
The National Dementia Strategy set out to improve the quality 
of life of individuals living with dementia. One objective included 
providing a higher quality of care [Dep09]. Three years later, 
Cameron’s Challenge on Dementia [Dep12] emphasised the drive 
for improvements in healthcare as well as better research.   The 
use of pharmacological interventions have been found to be both 
overprescribed for the treatment of behavioral disturbances 
[Ban09], and, ineffective in treating depression [BHD*11]. As a 
result, and in line with the national strategy, it was recommended 
that best practice should reflect the use of pharmacological inter-
ventions as a last resort only, to treat complex cases where non-
pharmacological interventions have proven unsuccessful.  The 
goal therefore remains to deliver non-pharmacological innova-
tions that support and enhance the quality of life and wellbeing of 
people living with dementia, with the aim of reducing distress and 
behavioral disturbance. 
1.2 Interventions in Dementia  
There is a growing evidence base demonstrating positive 
outcomes in non-pharmacological interventions. It is well 
established that good practice in the field of dementia care is 
underpinned by the principles of a person centred philosophy. 
Low intensity intervention examples include engagement in 
meaningful activity and social interaction [Lev08]. For example, a 
reduction in behaviour that challenges [KG00] and an 
improvement in cognition and mood have been found following 
reminiscence therapy, including life story review [WSJ*09]. High 
intensity protocol-led interventions tailored to specific 
presentations and needs such as music therapy [VBS03] have 
been shown to reduce agitation [LKL*14]. Similarly, cognitive 
stimulation therapy has proven to improve cognition [LMT07; 
WAS*12; MRN*13] and quality of life [STW*03; AHS*13]. Such 
approaches can be supported by specialist individualised 
formulation-led interventions [BMJ*13].  
1.3 Introduction to Virtual Reality Technology 
Technology is increasingly influencing the way we relate to the 
world around us, and, unsurprisingly, technological developments 
in the healthcare sector are following the same course. Virtual 
Reality (VR), a technology first introduced in the 1950s, is now 
becoming a massive success in the gaming industry, largely due 
to miniaturisation of electronics and declining hardware costs. VR 
is a technology that gives the user a Virtual Environment (VE) 
they can interact with. There are three types of virtual reality 
categorised by Ma and Zheng [11]: (1) a non-immersive VR 
experience creates a 3D environment wherein the user can 
navigate using a desktop, keyboard and mouse; (2) a semi-
immersive VR system uses higher performance graphics and is 
displayed on a large screen, which provides an increased sense 
of engagement with the VE compared to the non-immersive VE; 
(3) a fully-immersive system offers a head set which is worn by 
the user. The user receives both visual and auditory information 
via the headset. The fully-immersive VR experience can also be 
supported with additional equipment, for instance a mouse, a 
joystick or a rumble pad, which enables the user to interact within 
the VE [LMC11].  
1.4 Virtual Reality in Healthcare 
The use of VR in healthcare related applications has increased 
over time [SMT*08], introducing innovative non-pharmacological 
ways of delivering treatment and care. There are different types of 
VR rehabilitation strategies available including: ‘video-game like’ 
approaches with clear goals, progressions and rewards; 
‘exposure therapy’ which opens the user to specific simulated 
environments; and ‘teaching by example’ with step-by-step 
instructions.  Benefits of using VR for rehabilitation include 
economy of scale, not having to travel for treatment, and 
interactivity [Bur03]. Some of the pitfalls include the need for more 
evidence based research into the efficacy of VR and its 
application in healthcare, the initial cost of purchasing the 
equipment, and potential side effects (i.e. motion sickness).  
VR has been shown to be successful in the reduction of body 
dissatisfaction [RM97], as an intervention in psychotherapy 
[Riv05] and in the management of pain [MAS17; MAM*17; 
MAM*18]. VR has successfully been used in psychological 
treatment, particularly exposure therapy for the treatment and 
management of anxiety in the context of phobias [RH99]. In 
addition, the efficacy of VR exposure therapy was found to be 
similar to that of cognitive behavioural methods in reducing 
anxiety in fear of flying, panic disorder, social phobia, 
arachnophobia and acrophobia [OPG*12]. VR has also been 
used in the assessment and rehabilitation of people with brain 
injuries. Virtual equivalents of neuropsychological assessment 
have been created including the Wisconsin Card Sorting task 
(WCST) [RBR05] and the VR Multiple Errands Test (VMET) 
[CAS*14]. More recently, VR has been used to improve patients 
experience in a medical centre and was found to be successful in 
improving mood and providing a welcomed distraction [MRM*16].  
The growth of VR has increased considerably over the last four 
decades; with evidence of successful and promising application to 
different clinical populations. However, publications exploring the 
use of VR with people living with dementia have only been 
prominent across the last two decades, forming only a fraction of 
  
the overall VR literature (Table 1). Much of the research appears 
to focus on efficacy of VR interventions, task performance and 
physical health as well as treatment for anxiety and/or phobias.  
The application of VR in dementia populations is underdeveloped 
and the feasibility of VR systems with individuals living with 
dementia is unclear.  The evidence base for the feasibility of VR 
technology in terms of technology acceptability, user experience 
and practicality with this client group (i.e. safety) as well as its 
impact on the wellbeing and clinical presentation of individuals 
living with dementia, therefore, warrants further investigation.  At 
this stage our focus was not on efficacy of treatment or cost 
benefit analysis. 
 
Table 1: The growth of VR literature overall compared to 
literature relating to VR and dementia (21/09/2017). 
2. Aims and Objectives 
The aim of this paper was to conduct a review of the literature 
reporting on the feasibility of VR technology amongst individuals 
living with dementia. For the purpose of this review feasibility 
covered acceptability, practicality, and user experience as well as 
the effect on wellbeing.  
 Specific objectives were: 
1) To establish the different types of VR technology systems that 
have been used with individuals living with dementia. 
2) To explore whether the feasibility of VR technology has been 
investigated with individuals living with varying stages of demen-
tia.  
3. Method 
3.1 Search Strategy  
The Healthcare Databases Advanced Search Engine 
(HDASE) was used to identify relevant studies using the key word 
search with the assistance of a librarian. Three databases were 
included as part of the search: Medline, PsychINFO, and 
EMBASE. The search was conducted across all three databases 
via the HDASE, removing any duplicates,  and reflected the terms 
‘Dementia and Virtual Reality’ and/or ‘Virtual Reality Exposure 
Therapy’ which was searched by ‘thesaurus and/or title and 
abstract’. There were no studies returned from the specific search 
relating to VR and dementia prior to 1996 and, therefore, the 
search was conducted from 1996- 21st September 2017.   
Relevant studies were also sought using the ‘snowballing method’ 
consisting of: Google Scholar internet searches and reference 
lists from papers identified in the search.   
It is evident that VR is used within the wider healthcare sector 
for rehabilitation, with outcomes that measure task performance. 
However, it appears that less is known regarding the feasibility of 
using VR technology systems with individuals living with dementia 
including their user experience.  Consequently, this became the 
primary focus of the literature search, which is reflected in the 
inclusion and exclusion criteria below:   
3.2 Inclusion Criteria 
a) study included VR and participants with a diagnosis of 
dementia  
b) mention of feasibility of VR equipment for use with individuals 
living with dementia 
c) involved the application of VR (non-immersive/ semi-immersive 
VR and/or fully-immersive VR)  
d) reflected on the user experience in relation to VR  
3.3 Exclusion Criteria  
a) the publication was not in English 
b) the primary outcome measure did not include discussion of the 
feasibility of VR technology (i.e. the outcomes measured the 
performance of the participant for a given task only)  
c) studies limited to a review of the previous published studies   
d) non-peer reviewed publication type resources.   
3.4 Data Extraction  
Three researchers identified appropriate inclusion and 
exclusion criteria and implemented the criteria on a sample of the 
identified papers. Study relevance was evaluated using the 
researchers’ objectives, inclusion and exclusion criteria.  
4. Results 
Based on the stated search strategy, inclusion and exclusion 
criteria with the researcher’s objectives in mind, only five out of 
119 papers identified met all criteria and were included in this 
scoping review. Figure 1 describes the search strategy and the 
results. Table 2 displays the characteristics including the aims of 
the five relevant identified studies. 
Using semi-immersive VR, Flynn and colleagues [03] explored 
the usability of VR with individuals living with dementia in the 
early stages, when immersed in a large outdoor park VE. Partici-
pants reported little difficulty in using the joystick as well as find-
ing the overall experience enjoyable. High rates of ‘presence’ 
were found (the extent the participant felt they were really present 
in the VE) indicating that the VR intervention presented an eco-
logically valid environment. Overall, there were no significant 
increases or decreases in psychological and physical wellbeing 
observed post-intervention compared to pre-intervention in both 
participants living with dementia and a second group comprising 
carers. When looking at individual scores, however, one partici-
pant’s heart rate did increase considerably, resulting in the ses-
sion being stopped for safety reasons. The participant became 
frustrated trying to search for an item within the VE that she had 
seen in a previous session, which the authors predicted was likely 
to have contributed to the rapid rise in heart rate. There was no 
significant increase in symptoms of simulator sickness across 
participants with dementia and carers. Results must be interpret-
ed with caution however, as the Simulator Sickness Question-
naire for Individuals with Dementia (SSQPWD) and the Dementia 
Virtual Reality Use (DVRuse) tool [Kal99] used to test for adverse 
effects and usability of the VR application, were adapted, unvali-
dated versions of the originals. Thus, the psychometric properties 
are unknown and the validity of the findings potentially compro-
mised.  In addition, the DVRuse tool may have contributed as a 
confounding variable as questions were posed to participants 
whilst they were engaged in the VE, requiring them to divide their 
attention between the VE and the researcher. The authors report-
ed that the findings could not be generalised outside of the study 
Year  PsychINFO Medline Embase 
  VR VR & 
Dementia 
VR VR & 
Dementia 
VR VR & 
Dementia 
2007-2017  5809 37 4673 35 11, 570 86 
1996-2006  1941 8 1663 4 3736 10 
1985-1995  70 0 101 0 124 0 






due to the small sample size, however, a good insight into the 
potential feasibility amongst a small group of individuals living 
with dementia was established. 
Siriaraya and Ang [14] also used semi-immersive VR. The re-
sults highlighted experiences provided by a Virtual World (VW) 
invoking memories and creating a sense of self through virtual 
reminiscence, as well as providing participants with opportunities 
they would otherwise not have. One user of the gardening VW 
commented on wanting to grow a lily as she was unable to do this 

















Figure 1: Search results flow diagram. 
The authors commented that continuous use of some of the 
software, including the sensor equipment, caused fatigue. Fur-
ther, different VWs were more favourable amongst females com-
pared to males. In addition, negative memories were triggered in 
some individuals and emotional distress observed as an outcome 
(patients were redirected back to positive aspects for the VW to 
good effect). The perceived time it took for care staff to support in 
the implementation of the software was not favourable and partic-
ipants with more severe cognitive decline were unable to perform 
some simple touch screen tasks provided as part of the VR expe-
rience.  
Manera and colleagues [16] used semi-immersive VR to ex-
plore the feasibility of VR with individuals living with mild to mod-
erate dementia by comparing a paper and pencil exercise with 
VR. Participants reported feeling less secure in the VR condition, 
although this did not have a detrimental impact of how VR was 
viewed as participants were equally as interested in both interven-
tions. Overall, 68.4 percent of participants preferred the VR condi-
tion, with it being viewed as more immersive, engaging and moti-
vating compared to the paper condition. More participants (9 
individuals) continued engaging with VR when invited to, com-
pared to the paper condition (3 individuals). Interestingly, apathet-
ic participants were significantly more interested in the VR inter-
vention compared to non-apathetic participants. Whilst exploring 
task performance was not a primary aim of this literature search, 
it is worth noting that participants found more targets in the paper 
condition compared to the VR condition. Manera and colleagues 
concluded that some participants experienced difficulties with 
using the mouse, which may have contributed to reduced perfor-
mance in the study. 
Moyle, Jones, Dwan and Petrovich [17] also utilised semi-
immersive VR, however, to our knowledge, this study was the first 
to explore the feasibility of VR amongst individuals with a range of 
cognitive impairment from mild to more severe stages of demen-
tia.  The Virtual Reality Forest (VRF) was well received by indi-
viduals living with dementia, inferring its feasibility for this user 
group. It was perceived by participants with dementia, family 
members and staff to have a positive effect, including increased 
pleasure and alertness whilst immersed in the VE compared to 
norms from participants with dementia in a non-VR activity con-
text. There were no significant observations for anger and sad-
ness during the VR experience. Environmental stimulation also 
increased and apathy decreased during the VR intervention com-
pared to before and after the experience. Staff views were that a 
VRF was more stimulating for individuals in the later stages of 
dementia compared to earlier stages where they seemed to be-
come easily bored. There were also no significant differences 
between the observed types of engagement during the VRF.  
Nevertheless, there was evidence of adverse effects, as partici-
pants with dementia reportedly experienced more fear and anxie-
ty during the VRF experience when compared to the normative 
sample. Moyle and colleagues did not make inference as to what 
may have contributed to increased fear and anxiety; however, 
they suggested that results should be treated with caution due to 
the small sample size.  
The Mendez, Joshi and Jimenez [14] paper presented the only 
research identified in the current review that used fully-immersive 
VR.  Participants with behavioural variant frontotemporal demen-
tia wore a head mounted display to create a fully-immersive VE in 
which they were assessed using a structured interview facilitated 
by avatars. Participants tolerated the equipment well with no 
complaints of discomfort or distress. There were also no post 
intervention side effects for arousal, stress, anxiety, anger, fatigue 
and attention.  The results indicated high levels of presence as 
well as increased levels of interaction in the VR condition com-
pared to a real world condition.  The generalisations of the find-
ings were limited due to the small sample size. Nonetheless, the 
research did provide positive evidence for the feasibility of fully-
immersive VR with individuals living with dementia.   
5. Discussion 
It has become apparent that much of the current published 
research that includes both VR technology and participants living 
with dementia has been conducted within the context of 
assessment and task performance, without reference to the 
feasibility of the equipment or the user’s experience of the VR 
system. Given this was not specifically relevant to our area of 
interest; it is not surprising that the systematic search only 
revealed five relevant studies. We were interested in this specific 
area of feasibility to further explore the potential implementation 
of VR as a therapeutic activity with individuals living with more 
moderate to severe dementia. The practicality of using VR is 
uncertain due to various factors including presentation, risk and 
engagement of the individual.  Of those studies, participants were 
typically diagnosed with the mild to moderate stages of dementia. 
Only one paper explored the feasibility of VR with individuals 
living with dementia across a range of stages, which included 
more severe dementia. 
Overall, the five papers analysed revealed that the use of VR 
technology systems can be feasible amongst individuals with mild 
a)publication was not in English (4)  
b)the primary outcome measure was not the feasibility 
of VR equipment ( i.e. measured the performance of the 
participant for a given task only)  (12) 
c)participants without dementia, including caregiver 
studies, healthy control studies and individuals with a 
diagnosis other than dementia (51) 
d)studies were limited to a review of previously 
published studies (9)   
e)studies that did not include VR and dementia (20) 






5 relevant papers identified 
A total of 119 papers identified  
(114 electronic search method (removing duplicates) & 
5 from snowballing method (removing duplicates 
identified in academic search) 
  
to moderate dementia. With regard to clinical presentation, VR 
can have a positive impact on wellbeing, including an increase in 
pleasure and alertness futher validating the feasibility of VR 
[MJD*17]. On the contrary, there is also evidence of adverse 
effects of VR including negative memories [SA14] and an 
increase in fear and anxiety [MJD*17]. It was also reported that 
VR was more stimulating for individuals in the later stages of 
dementia compared to the earlier stages [MJD*17] implying that 
stage of dementia may be a variable that could potentially affect 
the VR experience. Elsewhere in the literature, potential negative 
side effects included nausea and disorientation [Che*11].  
With regards to the types of VR technology systems, the 
literature revealed that the head mounted display was feasible 
amongst participants living with dementia [MJJ14], but the 
additional equipment may not be, with some evidence of user 
difficulties [SA14; MCB16].  
6. Recommendations and Future Research  
In three of the five studies reviewed [FvSB*03; MJD*17; 
MJJ14], a small sample of 10 or less participants with dementia 
was recruited, making the applicability of findings limited. Future 
research should explore VR with larger populations to increase 
the generalisability and thus the validity of the research. 
Much of the published VR and dementia research has 
accessed participant populations with a diagnosis of either ‘mild’ 
or ‘mild to moderate’ dementia, living at home or in residential 
settings. This was evident in our review, with only one study that 
included participants living within the later stages of dementia 
[MJD*17] who resided in a residential care home. More research 
is needed with participants living within the later stages of 
dementia; however, there could be inherent challenges with this. 
Researchers should be aware of the potential ethical implications 
regarding capacity to consent to participation. 
 The Mental Capacity Act [05] guidelines should be referred to 
in relation to conducting research with individuals who may lack 
capacity. Capacity assessments, involving relatives or a suitable 
consultee, and maintaining assent are integral. With all potential 
participants living with dementia in future research, a number of 
factors for consideration have been highlighted. For example, the 
potential for detrimental psychological consequences, such as 
reported increased fear and anxiety [MJD*17], experience of 
negative memories [SA14], or exacerbation of existing cognitive 
difficulties, such as confusion and disorientation that may already 
be evident. Future studies involving VR should consider a method 
that minimises the potential for negative outcomes (such as fear) 
and maximises opportunity for well-being.   
Moyle and colleagues recommended that VR interventions 
should create “an engaging, attractive, and colourful interface that 
promises enjoyment” (p8, 2017). Due to individual differences, we 
feel that offering a choice of a VE may increase the opportunity 
for enjoyment if the VR user can select from a menu according to 
their preferences and could be considered within clinical 
applications as well as when carrying out future research. 
Furthermore, given the difficulty highlighted for some participants 
living with dementia using some of the additional equipment (e.g. 
a motion sensor or mouse) [MCB*16], future VR research could 
consider the design of the VR system and offer one that 
maximises opportunity to engage and interact with the VE with 
minimal equipment burden.   
Whilst the research conducted by Blackman, Van Schaik and 
Martyr [07] was excluded from the review (outcomes were based 
only on task performance), upon reflecting on their study they 
highlighted an important limitation in their design of the VR 
software, which is deemed relevant here. In their study, poor 
resolution of the sign posts in the VE made it difficult for 
participants to read them. They conclude that this may have had 
a detrimental effect on the virtual experience, lowering individual 
performance and decreasing the ecological validity of the VE. 
This is a simple yet valuable design issue that can be considered 
for clinical interventions or future studies and easily resolved to 
increase presence for the VR user in the VE.   
7. Limitations of Current Review 
The small review sample size of five papers is open to critique. 
Further, each of the reviewed studies used small participant 
numbers. Given that the area of interest is in its infancy perhaps 
this is not unexpected at this stage. We have been unable to look 
at publication bias or selective reporting within the literature. 
Therefore, we have been unable to comment on the risk of bias 
within the limited cumulative evidence generated to date. We also 
only included papers in English, excluding four papers without 
knowing the applicability of the content. If a future review were to 
be carried out, given the sparseness of research in this particular 
field, the researcher could explore the translation of foreign 
papers in order to establish applicability to the research area with 
a view to potentially widening the sample size. Further, the 
reviewer could consider exploring a wider variety of databases 
that focus upon the technical field of VR but which may also 
address the focus of this review directly or indirectly.  
In addition, whilst inclusion and exclusion criteria were selected 
by three of the researchers, the method of including or excluding 
papers was completed mainly by one researcher and may 
potentially have contributed to a selection bias with regards to 
identifying relevant papers. It should be noted, however, that 
discussions were held with regards to the criteria, and a selection 
of papers were examined in order to ensure confidence in the 
process and that selection was similar across the three 
researchers. Consultation was sought with the additional two 
researchers in any instance where the reviewer was unsure as to 
whether a paper met the criteria.  
8. Conclusion 
The current paper aimed to specifically explore the feasibility of 
VR technology system use with individuals living with a dementia 
that included acceptability, practicality, user experience and the 
effects on well-being. It is perhaps not surprising that only four 
percent of the literature identified from the search was relevant, 
demonstrating the infancy of an area which warrants further 
investigation. Of the relevant literature identified, there is 
evidence that both semi-immersive and fully-immersive VR 
technology can be feasible amongst individuals living within the 
earlier stages of dementia outside of a hospital environment. 
Comfortable equipment resulted in views of VR as a welcome 
distraction that increased alertness and pleasure. However, some 
individuals in the earlier stages of dementia experienced 
boredom, and VR technology was also found to increase fear and 
anxiety in one study. In order to further develop this field and add 
to the person-centred intervention toolbox available for people 
with a dementia diagnosis, more feasibility research is required. 
The current evidence-base leaves a predominant gap around the 
exploration of VR technology system use for people within the 
moderate to later stages of dementia, living in a hospital 





Authors Participant population VR equipment  
& exposure 
Study aims Method Outcome measures Results 
FvSB*03 -recruited from the local health 
service and Alzheimer’s 
Society 
-n=6 people with dementia 
(specific diagnosis 
undisclosed) 
(n=3 male, n=3 female; age 
range 52-91) 
-early stage dementia  
-n=6  carers (controls) 
-semi-immersive VR 
auditorium, 140 degree 
curved screen based on 
BARCO 1208 projectors; 
surround sound; BG 
systems Flybox © joystick 
navigation. 
-park environment 
≤ 20 minutes exposure to 
VR at any 1 time 
-explore the 




-exercise 1: instructed to explore the 
VE however they wished using the 
joystick. The participant was asked 
questions whilst they explored the VE 
-exercise 2: participants were given 
prompts to carry out functional tasks 
in the VE 
-SSQPWD self-report pre 
and post intervention  
-DVRuse questionnaire  
during intervention (people 
with dementia) 
-self-rated wellbeing (5 point 
scale, 1=very comfortable, 
to 5 very uncomfortable)   
-physical wellbeing 
(people with dementia only) 
measured using heart rate 
(HR) by beats per minute 
 
-participants felt in control of 
the VR with little difficulty in 
using a joystick for 
navigating the VE and 
viewed the VE’s as 
naturalistic.  
-VR was viewed as a good 
way to assess functional 
behaviour 
-no increase in simulator 
sickness or adverse effects 
including psychological or 
physical well-being 
 
SA14 -recruited from 2 care home 
across South East England 
-n=20 residents with dementia 
(specific diagnosis 




-n=2 care home managers 
- stage of dementia 
undisclosed 
-semi-immersive 
-virtual world (VW) created 
using Unity3D 
-Microsoft Kinect®  sensor 
for gesture and touch-based 
interactions 
-Zigfu development kit 
facilitated the development 
of the gesture software 
through Unity3D 
-to explore the use 
of a VW to support 
life engagement in 
individuals with 
dementia residing 
in a long term care 
environment 
-9 visits over 2 care homes during 8 
months 
- groups of 1-5 participants were 
offered the opportunity to engage 
with the VW in an activity room and 
were free to enter and leave as they 
wished 
-VW presented on a large screen and 
arm gestures were captured through 
arm movements so the participant 
could engage whilst seated  
-3 different VW prototypes offered: 
virtual reminiscence room; river tour; 
gardening  
 
-researchers observed the 
participants interacting with 
the VW and made detailed 
notes  
-2 focus groups with care 
staff and managers to 
discuss design of the VW  
-opened ended interviews to 
discuss opinions of the 
prototypes and clarify 
observations  
-thematic analysis was used 
to categorise themes from 
the data 
 
-VW invoked memories and 
created a ‘sense of self’ 
through reminiscence 
-provided opportunities that 
participants would not have 
had 
-continued use of 
equipment caused fatigue 
-triggered some negative 
memories 
MJJ14 -recruited from a university 
based clinical program 
-n=5 with bvFTD (n=2 men, 
n=3 female; mean age 56, SD 
12.8 years) 
-MMSE mean  21.3 SD 7.3 
-CDR mean 1.0 SD 0.0 
-fully immersive 
eMargin Z800 HMD that 
included: a separate display 
screens for each eye; 
integrated head tracking; 
stereo earphones 
- to assess the 
feasibility of 
placing individuals 




-exercise 1: participants completed 
the UCLA structure insight interview 
(Mendez & Shapira, 2001, cited by 
Mendez et al., 2014) with a real life 
researcher 
-exercise 2: participants were 
immersed in a VE in which they were 
seated at a conference table and 
answered insight questions (from a 
subset of the UCLA Insight Interview 
on cognitive insight) posed by 5 
avatars also seated at the virtual 
table 
 
-verbal fluency tested with 
MLU 
-number of head turns 
towards the avatars in the 
VE 
-self-report standardised 
Likert scale to measure 
levels of arousal; stress; 
anxiety; anger; fatigue; 
attention  
-HR BioHarness 3.9 
-Biopac Acqknowledge 
program to determine intra-
subject differences 
 
-participants tolerated the 
head-mounted without 
adverse effects  
-presence was 
demonstrated through 
participants interaction in 
the VR   
-participants with bvFTD 
demonstrated larger mean 
length of verbal utterances 
compared to interviews in 
the real world 
MCB*16 -recruited from research 
centres in France 
-n=29 with dementia (n=15 
Alzheimer’s disease, n=10 
mixed dementia, n=1 vascular 
dementia, n=2 primary 
progressive aphasia, n=1 
organic brain syndrome; n=12 
female, n=17 male; mean age 
76.3 years; SD 7.2; age range 
65–90 years) 
-n= 28 with MCI  (n=13 female, 
n=15 male; mean age 75.0 
years; SD 6.8; age range 62–
89 years) 
-MMSE mean: dementia 20.2, 
SD 3.1; MCI 25.4. SD 2.6 
-semi-immersive, VE 
displayed a well-known 
square in Nice created by 
reconstructing the 3D 
environment from a set of 
photos. The VE include 
animated 3D characters  
- displayed on a Barco 
OverView OLSF-721 full 
HD 3D stereoscopic LED 
video wall with a resolution 
of 1920 x 2160 pixels, 1.55 
x 1.74 meters 
-participants wore Volfoni 
Edge 1.2 active 3D LCD 
shutter glasses, 
synchronized with a Volfoni 




feasibility of a VR 
tool for measuring 
attention in 
individuals with 
MCI and dementia 





usability of the VR 
intervention 
-attention task completed across two 
conditions (VR/paper based) 
-required participants to find and 
select 5 females wearing a t-shirt that 
met the specified 
criteria(colour/pattern/colour and 
pattern)  
- the paper based condition used 
screen shots from the VE  
-participants played for 5 minutes in 
each condition 
- participants were asked to select 
the 5 targets across 8 different 
criterion scenes (using a mouse in 
the VR condition, and placing a 
rectangle over the target in the paper 
condition) 
-number or errors and correctly 
identified targets were recorded 
 
-self report questionnaires 
to evaluate: satisfaction, 
interest; discomfort; anxiety; 
feeling of security and 
fatigue in relation to both 
conditions  
-scale ranged from ‘not at 
all’ to extremely’ 
-the number of correctly and 
incorrectly identified targets 
in the attention task 
-participants with MCI and 
dementia were satisfied and 
interested in the task using 
VR 
-participants reported 
feelings of security and no 
adverse effects (i.e. 
discomfort, anxiety and 
fatigue)  
-all participants preferred 
the VR condition, however 
apathetic participants more 
so than non- apathetic 
participants 
MJD*17 -recruited from 2 residential 
aged care facilities in Australia  
-n=10 people with a dementia 
(n=7 Alzheimer’s disease; n=3 
undisclosed; n= 3 male; n= 7, 
female; ages undisclosed)  
-n= 10 family member  
-n= 9 care staff 
-PAS scores ranged 7.35-20, 
mean 13.21 
-semi-immersive VR forest 
(VRF) via a large interactive 
screen 
-video game technology 
including sensors through 
Microsoft Kinect® allowing 
participants 
to interact with the scene  
by moving their arms and 
hands 
-explored the 
effectiveness of a 
VRF on 
engagement, 
apathy and mood 




using VRF from 
the perspectives of 
staff, carers and 
people with 
dementia in a 
residential aged 
care facility 
-the VRF was set up across in 2 
different care homes: one was dark 
and calm, the other was a bright and 
noisy 
-both groups of participants were 
exposed to a VRF session for a 
maximum of 15 minutes 
- OERS  
- PEAR 
-type of engagement: coded 





analysed with thematic 
analysis 
-the VRF was perceived as 
having a positive effect by 
all participants  
-people with dementia 
experienced: more pleasure 
(p= .008); more alertness 
(p<.001); more fear/anxiety 
(p<.016) than a comparative 
normal sample 
 Table 2: Summary of studies identified following the application of inclusion and exclusion criteria.   
Abbreviations: SSQPWD: Simulator Sickness Questionnaire adapted for people with dementia (unvalidated measure adapted from the SSQ Kennedy, Lane & Berbaun, 1993, cited by Flynn et al., 
2003); DVRuse questionnaire: Dementia Virtual Reality Use questionnaire (unvalidated measure adapted from the VRuse questionnaire, Kalawsky, 1999, cited by Flynn et al., 2003, unvalidated 
version); MCI: mild cognitive impairment; PAS: Psychogeriatric Assessment Scale (Jorm et al., 1995, cited by Moyle et al., 2017); PEAR: Person-Environment Apathy Scale (Jao et al., 2015, cited 
by Moyle et al., 2017); OERS: Observed emotional rating scale (Lawton et al., 1999, cited by Moyle et al., 2017); bvFTD: behavioural variant frontotemporal dementia; MMSE: Mini Mental State 
Examination (Folstein, Folstein & McHugh 1975 cited by Blackman et al.,2007); CDR: Clinical Dementia rating scale (Morris, 1993, cited by Mendez  et al., 2014); MLU: mean length of utterance. 
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